Risuteganib hydrochloride

Risuteganib hydrochloride is a small molecule anti-integrin agent designed to mitigate oxidative stress and promote retinal homeostasis in dry AMD research. It functions by selectively targeting specific integrin receptors implicated in the disease pathology, showing potential for both in vitro mechanistic studies and in vivo preclinical models.